In this study, we also showed that activation of Wnt/β-catenin signalling by a specific GSK-3 inhibitor in hepatoma cell lines decreased the susceptibility to IFN-α/5-FU through a reduction in their DNA synthesis inhibitory effects and regulation of cell cycle progression. Here, IFNA1 is linked to hepatocellular carcinoma.